114 related articles for article (PubMed ID: 38928133)
1. Immune Response Dynamics and Biomarkers in COVID-19 Patients.
Ranjbar M; Cusack RP; Whetstone CE; Brister DL; Wattie J; Wiltshire L; Alsaji N; Le Roux J; Cheng E; Srinathan T; Ho T; Sehmi R; O'Byrne PM; Snow-Smith M; Makiya M; Klion AD; Duong M; Gauvreau GM
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928133
[TBL] [Abstract][Full Text] [Related]
2. Behavior of Eosinophil Counts in Recovered and Deceased COVID-19 Patients over the Course of the Disease.
Cortés-Vieyra R; Gutiérrez-Castellanos S; Álvarez-Aguilar C; Baizabal-Aguirre VM; Nuñez-Anita RE; Rocha-López AG; Gómez-García A
Viruses; 2021 Aug; 13(9):. PubMed ID: 34578258
[TBL] [Abstract][Full Text] [Related]
3. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.
Pons MJ; Ymaña B; Mayanga-Herrera A; Sáenz Y; Alvarez-Erviti L; Tapia-Rojas S; Gamarra R; Blanco AB; Moncunill G; Ugarte-Gil MF
Front Immunol; 2021; 12():700921. PubMed ID: 34539631
[TBL] [Abstract][Full Text] [Related]
4. Normalization of eosinophil count is predictive of oxygen weaning over the course of COVID-19 infection among hospitalized adults during the first wave of 2020 pandemic.
Davido B; Jaffal K; Saleh-Mghir A; Vaugier I; Bourlet S; De Truchis P; Annane D
Front Immunol; 2024; 15():1381059. PubMed ID: 38855100
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Peripheral Eosinophil Counts and Eosinophil to Lymphocyte Ratio (ELR) in the Clinical Course of COVID-19 Patients: A Retrospective Study.
Georgakopoulou VE; Garmpis N; Damaskos C; Valsami S; Dimitroulis D; Diamantis E; Farmaki P; Papageorgiou CV; Makrodimitri S; Gravvanis N; Velonias S; Sklapani P; Trakas N; Antoniou EA; Kontzoglou K; Nikolidakis L; Damaskou Z; Syllaios A; Marinos G; Vogiatzi G; Korrou GE; Kyriakos G; Quiles-Sanchez LV; Patsouras A; Lamprinos D; Stelianidi A; Savvanis S; Garmpi A
In Vivo; 2021; 35(1):641-648. PubMed ID: 33402521
[TBL] [Abstract][Full Text] [Related]
6. Cytokine Profiles Before and After Immune Modulation in Hospitalized Patients with COVID-19.
Azmy V; Kaman K; Tang D; Zhao H; Dela Cruz C; Topal JE; Malinis M; Price CC
J Clin Immunol; 2021 May; 41(4):738-747. PubMed ID: 33459964
[TBL] [Abstract][Full Text] [Related]
7. Eotaxin-3 as a Plasma Biomarker for Mucosal Eosinophil Infiltration in Chronic Rhinosinusitis.
Yamada T; Miyabe Y; Ueki S; Fujieda S; Tokunaga T; Sakashita M; Kato Y; Ninomiya T; Kawasaki Y; Suzuki S; Saito H
Front Immunol; 2019; 10():74. PubMed ID: 30778348
[No Abstract] [Full Text] [Related]
8. Characterization of eosinophils and detection of eotaxin in skin chamber fluid after challenge with relevant allergen in patients with mild asthma.
Fernvik E; Grönneberg R; Lundahl J; Raud J; Zetterström O; van Hage-Hamsten M; Halldén G
Clin Exp Allergy; 1999 Nov; 29(11):1516-25. PubMed ID: 10520080
[TBL] [Abstract][Full Text] [Related]
9. COPD patients with high blood eosinophil counts exhibit a lower rate of omicron infection and milder post-infection symptoms.
Bai X; Niu Y; Wei S; Zhu Z; Xu M; Liu H; Liu X; Wang R
Clin Respir J; 2024 Jun; 18(6):e13790. PubMed ID: 38817043
[TBL] [Abstract][Full Text] [Related]
10. Interplay of Antibody and Cytokine Production Reveals CXCL13 as a Potential Novel Biomarker of Lethal SARS-CoV-2 Infection.
Horspool AM; Kieffer T; Russ BP; DeJong MA; Wolf MA; Karakiozis JM; Hickey BJ; Fagone P; Tacker DH; Bevere JR; Martinez I; Barbier M; Perrotta PL; Damron FH
mSphere; 2021 Jan; 6(1):. PubMed ID: 33472985
[TBL] [Abstract][Full Text] [Related]
11. Eosinophils and Chronic Respiratory Diseases in Hospitalized COVID-19 Patients.
Valverde-Monge M; Cañas JA; Barroso B; Betancor D; Ortega-Martin L; Gómez-López A; Rodríguez-Nieto MJ; Mahíllo-Fernández I; Sastre J; Del Pozo V
Front Immunol; 2021; 12():668074. PubMed ID: 34149705
[TBL] [Abstract][Full Text] [Related]
12. The role of peripheral blood eosinophil counts in COVID-19 patients.
Xie G; Ding F; Han L; Yin D; Lu H; Zhang M
Allergy; 2021 Feb; 76(2):471-482. PubMed ID: 32562554
[TBL] [Abstract][Full Text] [Related]
13. Eosinophil and T cell markers predict functional decline in COPD patients.
D'Armiento JM; Scharf SM; Roth MD; Connett JE; Ghio A; Sternberg D; Goldin JG; Louis TA; Mao JT; O'Connor GT; Ramsdell JW; Ries AL; Schluger NW; Sciurba FC; Skeans MA; Voelker H; Walter RE; Wendt CH; Weinmann GG; Wise RA; Foronjy RF
Respir Res; 2009 Nov; 10(1):113. PubMed ID: 19925666
[TBL] [Abstract][Full Text] [Related]
14. The Systemic Immune Response in COVID-19 Is Associated with a Shift to Formyl-Peptide Unresponsive Eosinophils.
Koenderman L; Siemers MJ; van Aalst C; Bongers SH; Spijkerman R; Bindels BJJ; Giustarini G; van Goor HMR; Kaasjager KAH; Vrisekoop N
Cells; 2021 May; 10(5):. PubMed ID: 34062964
[TBL] [Abstract][Full Text] [Related]
15. Role of immune mediators in predicting hospitalization of SARS-CoV-2 positive patients.
Ashrafzadeh-Kian S; Campbell MR; Jara Aguirre JC; Walsh J; Kumanovics A; Jenkinson G; Rinaldo P; Snyder MR; Algeciras-Schimnich A
Cytokine; 2022 Feb; 150():155790. PubMed ID: 34991059
[TBL] [Abstract][Full Text] [Related]
16. Eotaxin in induced sputum of asthmatics: relationship with eosinophils and eosinophil cationic protein in sputum.
Yamada H; Yamaguchi M; Yamamoto K; Nakajima T; Hirai K; Morita Y; Sano Y; Yamada H
Allergy; 2000 Apr; 55(4):392-7. PubMed ID: 10782526
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal Cytokine Profile in Patients With Mild to Critical COVID-19.
Ling L; Chen Z; Lui G; Wong CK; Wong WT; Ng RWY; Tso EYK; Fung KSC; Chan V; Yeung ACM; Hui DSC; Chan PKS
Front Immunol; 2021; 12():763292. PubMed ID: 34938289
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.
Azar MM; Shin JJ; Kang I; Landry M
Expert Rev Mol Diagn; 2020 Nov; 20(11):1087-1097. PubMed ID: 32990479
[TBL] [Abstract][Full Text] [Related]
19. The kinetics of allergen-induced eotaxin level in nasal lavage fluid: its key role in eosinophil recruitment in nasal mucosa.
Terada N; Hamano N; Kim WJ; Hirai K; Nakajima T; Yamada H; Kawasaki H; Yamashita T; Kishi H; Nomura T; Numata T; Yoshie O; Konno A
Am J Respir Crit Care Med; 2001 Aug; 164(4):575-9. PubMed ID: 11520718
[TBL] [Abstract][Full Text] [Related]
20. Cytokine profiles in the detection of severe lung involvement in hospitalized patients with COVID-19: The IL-8/IL-32 axis.
Bergantini L; d'Alessandro M; Cameli P; Otranto A; Luzzi S; Bianchi F; Bargagli E
Cytokine; 2022 Mar; 151():155804. PubMed ID: 35063722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
